AstraZeneca to build US$1.5 billion cancer drug manufacturing plant in Singapore
AstraZeneca plans to build a US$1.5 billion manufacturing facility in Singapore to produce antibody-drug conjugates (ADCs) and targeted cancer therapies, the British company said on Monday (May 20). The facility, which will be the drugmaker's first end …